Prospective trial of Adipose-Derived Regenerative Cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial



      Women undergoing breast conservation therapy (BCT) for breast cancer are often left with contour defects and few acceptable reconstructive options. RESTORE-2 is the first prospective clinical trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat grafting for reconstruction of such defects. This single-arm, prospective, multi-center clinical trial enrolled 71 patients post-BCT with defects ≤150 mL.


      Adipose tissue was collected via syringe lipoharvest and then processed during the same surgical procedure using a closed automated system that isolates ADRCs and prepares an ADRC-enriched fat graft for immediate re-implantation. ADRC-enriched fat graft injections were performed in a fan-shaped pattern to prevent pooling of the injected fat. Overall procedure times were less than 4 h. The RESTORE-2 protocol allowed for up to two treatment sessions and 24 patients elected to undergo a second procedure following the six month follow-up visit.


      Of the 67 patients treated, 50 reported satisfaction with treatment results through 12 months. Using the same metric, investigators reported satisfaction with 57 out of 67 patients. Independent radiographic core laboratory assessment reported improvement in the breast contour of 54 out of 65 patients based on blinded assessment of MRI sequence. There were no serious adverse events associated with the ADRC-enriched fat graft injection procedure. There were no reported local cancer recurrences. Injection site cysts were reported as adverse events in ten patients.


      This prospective trial demonstrates the safety and efficacy of the treatment of BCT defects utilizing ADRC-enriched fat grafts.



      BCT (breast conservation therapy), ADRC (adipose-derived regenerative cells)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Churgin S.
        • Isakov R.
        • Yetman R.
        Reconstruction options following breast conservation therapy.
        Cleve Clin J Med. March 2008; 75: S24-S29
        • Saint-Cyr M.
        • Rojas K.
        • Colohan S.
        • et al.
        The role of fat Grafting in reconstructive and cosmetic breast surgery: a review of the literature.
        J Reconstr Microsurg. 2011; ([Epub ahead of print])
        • ELFadl D.
        • Garimella V.
        • Mahapatra T.
        • et al.
        Lipomodelling of the breast: a Review.
        Breast. 2010; 19: 202-209
        • Zuk P.
        • Zhu M.
        • Mizuno H.
        • et al.
        Multilineage cells from human adipose tissue: implications for cell-based therapies.
        Tissue Eng. 2001; 7: 211-228
        • Matsumoto D.
        • Sato K.
        • Gonda K.
        • et al.
        Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection.
        Tissue Eng. 2006; 12: 3375-3382
        • Zhu M.
        • Zhou Z.
        • Chen Y.
        • et al.
        Supplementation of fat grafts with adipose-derived regenerative cells (ADRCs) improves long-term graft retention.
        Ann Plast Surg. 2009; 63: 222-228
        • Sterodimas A.
        • de Faria J.
        • Nicaretta B.
        • et al.
        Autologous fat transplantation versus adipose-derived stem cell-enriched lipografts: a study.
        Aesthet Surg J. 2011; 31: 682-693
      1. Toyoda M, Bukrinksy A, Eguchi M, et al. Autologous fat grafting for breast reconstruction: characterization of graft composition and effects on tumor growth in vivo. Eur J Surg Oncol. Under review.

        • Fraser J.
        • Wulur I.
        • Alfonso Z.
        • Hedrick M.
        Fat tissue: an underappreciated source of stem cells for biotechnology.
        Trends Biotechnol. 2006; 24: 150-154
        • Yoshimura K.
        • Suga H.
        • Eto H.
        Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation.
        Regen Med. 2009; 4: 265-273
        • Akita S.
        • Akino K.
        • Hirano A.
        • et al.
        Mesenchymal stem cell therapy for cutaneous radiation syndrome.
        Health Phys. 2010; 98: 858-862
        • Tiryaki T.
        • Findikli N.
        • Tiryaki D.
        Staged stem cell-enriched tissue (SET) injections for soft tissue augmentation in hostile recipient areas: a preliminary report.
        Aesthetic Plast Surg. 2011; 35: 965-971
        • Lin K.
        • Matsubara Y.
        • Masuda Y.
        • et al.
        Characterization of adipose tissue-derived cells isolated with the Celution system.
        Cytotherapy. 2008; 10: 417-426
        • Clough K.
        • Cuminet J.
        • Fitoussi A.
        • et al.
        Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction.
        Ann Plast Surg. 1998; 41: 471-481
      2. LENT SOMA Scales for all anatomic sites.
        Int J Radiat Oncol. 1995; 31: 1049-1091
        • Ware J.E.
        SF-36 Update.
        Spine. 2000; 25: 3130-3139
        • Likert R.
        A technique for the Measurement of Attitudes.
        Arch Psychol. 1932; (No. 140)
        • Carvajal J.
        • Patino J.
        Mammographic findings after breast augmentation with autologous fat injection.
        Aesthet Surg J. 2008; 28: 153-162
        • Veronesi U.
        • Cascinelli N.
        • Mariani L.
        • et al.
        Twenty year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.
        N Engl J Med. 2002; 347: 1227-1232
      3. The Cochrane Collaboration., [accessed 01.03.11].

        • Delay E.
        • Garson S.
        • Tousson G.
        • Sinna R.
        Fat injection to the breast: technique, results, and indications based on 880 procedures over 10 years.
        Aesthet Surg J. 2009; 29: 360-376
        • Illouz Y.G.
        • Sterodimas A.
        Autologous fat transplantation to the breast: a personal technique with 25 years of experience.
        Aesthetic Plast Surg. 2009; 33: 706-715
        • Rigotti G.
        • Marchi A.
        • Stringhini P.
        • et al.
        Determining the oncological risk of autologous lipoaspirate grafting for post-mastectomy breast reconstruction.
        Aesthetic Plast Surg. 2010; 34: 475-480
        • Petit J.Y.
        • Lohsiriwat V.
        • Clough K.B.
        • et al.
        The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study-Milan-Paris-Lyonexperience of 646 lipofilling procedures.
        Plast Reconstr Surg. 2011; 128: 341-346
        • Petit J.Y.
        • Botteri E.
        • Lohsiriwat V.
        • et al.
        Locoregional recurrence risk after lipofilling in breast cancer patients.
        Ann Oncol. 2011;